Our study also looked at cell-mediated immune activation and recognition of GA-DM-treated melanoma in vitro by using whole HSA protein or HSA64 76K peptide as a model for the study of Ag processing and presentation to specific CD4+ T cells. The gene discussed is CD4; the disease is melanoma.